Trial Profile
A Study of the Acute Hemodynamic and Myocardial Effects of Nesiritide in Diastolic Heart Failure.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 11 May 2010 Planned end date changed from 1 Feb 2005 to 1 Feb 2010 as reported by ClinicalTrials.gov record.
- 21 Nov 2006 New trial record.